Fig. 4From: Analysis of stromal PDGFR-β and α-SMA expression and their clinical relevance in brain metastases of breast cancer patientsOverall survival (OS) analyses using the Kaplan-Meier estimator and log-rank test were performed according to age (A), PDGFR-β expression (B), α-SMA expression (C), molecular subtype of BCBM (D), presence of extracranial metastasis (E), and multiplicity of BM lesions (F)Back to article page